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Endovascular stenting to treat chronic
long-segment inferior vena cava occlusion
Mark R. Robbins, MD, Zacharia Assi, MD, and Anthony J. Comerota, MD, Toledo, Ohio
Chronic inferior vena cava (IVC) occlusion is often associated with debilitating symptoms. Supportive therapy is the
treatment offered to most patients, often with poor symptom control. Patients have had to learn to cope with the sequelae
of the syndrome and to accept lifelong disability and pain. This may no longer be the case, because endovascular
procedures have emerged as a promising alternative for treatment of chronic IVC occlusion. We present 2 case reports of
long-standing long-segment IVC occlusion successfully treated with endovascular procedures that incorporated progres-
sive balloon dilation and stenting. The remarkably rapid relief of pain and swelling and overall improvement in quality
of life warrants attempts to correct the condition in other patients with IVC occlusion. (J Vasc Surg 2005;41:136-40.)Chronic occlusion of the inferior vena cava (IVC) is an
uncommon condition, with a variety of underlying dis-
eases. Patients have a myriad of signs and symptoms, which
vary dependent on collateral venous drainage. Symptoms at
presentation include bilateral lower extremity pain and
edema; skin changes such as eczema, pigmentation, and
ulceration; back pain; inguinal, abdominal, and thoracic
varicosities; and occasionally, impaired kidney or liver func-
tion if the renal veins or intrahepatic vena cava are in-
volved.1,2 Medical treatment, including anticoagulation
therapy, mechanical compression, and leg elevation, has
yielded suboptimal results. Surgical therapy has been re-
served for the most severe cases, and although some reports
show beneficial results, this patient population tends to
have significant comorbid conditions and long segment
central venous occlusion, making surgical intervention
risky and associated with a high failure rate. Initial results
with percutaneous transluminal angioplasty (PTA) were
good, but long-term patency with PTA in venous disease
has been disappointing.3,4 Recently endovascular stent
placement has emerged as a promising option for treatment
of chronic caval occlusion. We present 2 patients with
chronic, postthrombotic IVC occlusion who were being
observed, with the suggestion that nothing more could be
done. Both patients underwent successful treatment with
endovascular procedures with progressive balloon dilation
and stenting, resulting in remarkable clinical improvement.
CASE REPORTS
Case 1. A 22-year-old woman with factor V Leiden defect
had a 3-year history of worsening right leg swelling and symptom-
atic varicosities, despite therapeutic anticoagulation. Magnetic res-
onance images suggested postthrombotic narrowing of the intra-
hepatic IVC and occlusion of the infrahepatic IVC, iliac veins, and
common femoral veins. Access to the right internal jugular vein
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136and both common femoral veins was obtained with ultrasound
guidance. Using a glide wire and multiple catheters, recanalization
of the IVC from the right internal jugular approach was unsuccess-
ful, but the IVCwas successfully recanalized from the right femoral
approach (Fig 1, A-C). An Amplatz wire was introduced from the
right groin and snared from the right internal jugular vein, giving
through-and-through access. Balloon dilation of the IVC to 16
mm and the right iliac vein to 10 mm was accomplished. Two
overlapping 18  60-mm Wallstents (Boston Scientific) were
deployed from the right femoral approach, extending from the
hepatic veins to the distal IVC (Fig 1, D). The right common iliac
and external iliac veins were stented with 16  60-mm and 14 
40-mm Wallstents, respectively. The right internal jugular ap-
proach was then used to deploy a 12 40-mm and a 10 40-mm
stent in the right common femoral vein to cover the previous
puncture. An attempt was made to recanalize the left iliac vein, but
because the left leg was asymptomatic and had well-formed collat-
eral vessels, ongoing attempts at a difficult left leg canulation were
abandoned. A completion phlebogram showed uninterrupted ve-
nous drainage from the right femoral vein to the right atrium, with
the expected disappearance of the collateral veins (Fig 1, D). The
right lower extremity swelling significantly improved within 24
hours, and the symptoms were relieved. The patient received full
anticoagulation with unfractionated heparin during the procedure.
The heparin was stopped when the sheaths were removed, and was
resumed 2 hours later. The patient was switched to oral anticoag-
ulation therapy, because of the history of factor V Leiden defect. In
addition, clopidogrel (Plavix) was prescribed for 6 weeks, and 81
mg of aspirin indefinitely. At 3-month and 6-month follow-up the
patient had mild varicosities that required compression therapy,
but the pain and swelling were almost completely resolved.
Case 2. A 72-year-old man with a history of primary scleros-
ing cholangitis had been treated by the vascular surgery service for
several months because of severe postthrombotic syndrome. He
had a 3-year history of IVC occlusion that resulted in severe
bilateral lower extremity edema and chronic venous claudication.
Treatment with anticoagulation therapy, pneumatic and elastic
compression, and leg elevation provided only marginal relief of
symptoms.
Iliocavograms demonstrated occlusion of the IVC from the
hepatic veins to the IVC bifurcation. Both iliac arteries were
patent, but with chronic narrowing of the left iliac artery (Fig 2, A
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Volume 41, Number 1 Robbins, Assi, and Comerota 137Fig 1. Access to inferior vena cava (IVC) through occluded right common femoral vein and iliac vein. Venograms
reveal occluded IVC with collateralization (A), recanalization of occluded common iliac vein (B), and IVC (C). D,
Completion phlebogram shows uninterrupted venous drainage through stented femoral and iliac vein, and distal IVC.
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Completion phlebogram shows unobstructed flow through stented inferior vena cava. D, Two months after initial
stenting, inferior vena cava is still widely patent.
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ultrasound guidance, and 7F sheaths were placed. The entire IVC
was recanalized from the right femoral approach with a Kumpe
catheter and a glide wire. The Kumpe catheter, which was sup-
ported by a sheath, was helpful in keeping the wire from slipping
into the collateral veins and in creating a tract along the expected
course of the native IVC. Despite 1 uneventful perforation, the
wire was passed from the iliac vein into the intrahepatic IVC, and
the tract was dilated to 16 mm.
Six overlapping 20-mm to 50-mm Gianturco Z stents (Cook)
were deployed in the IVC, with the most proximal stent at the IVC
right atrial junction and the distal stent terminating just above the
IVC bifurcation (Fig 2, C). The stents were dilated to 16 mm. A
14-mm to 60-mm Wallstent was deployed in the left external iliac
vein, because that lesion consistently demonstrated post-dilation
recoil.
The patient’s lower extremity discomfort and tense tissue
pressure notably diminished within hours of caval recanalization.
The patient was discharged with warfarin sodium (Coumadin),
with a target international normalized ratio of 2.0 to 3.0, and 81
mg of aspirin daily. At 1-month follow-up the edema hadmarkedly
improved with compression therapy, and the patient had near
normal anatomy of the legs and significant relief of symptoms. Two
months later the patient returned with recurrent bilateral leg
edema. Phlebograms revealed a widely patent IVC (Fig 2,D). The
edema was secondary to profound hypoalbuminemia and progres-
sive liver disease, from which he ultimately died.
DISCUSSION
These case reports demonstrate the rapid and dramatic
improvement that can be achieved with relief of chronic
IVC occlusion that is causing unrelenting lower extremity
venous hypertension. In patients with symptomatic chronic
venous occlusive disease supportive measures are often the
only therapy offered. Medical management alone has
shown poor results. Surgical reconstruction of central ve-
nous occlusion is infrequently recommended, because of its
associated morbidity and marginal results. Gloviczki et al5
reported their experience with operative venous recon-
struction in 28 patients with superior vena cava or iliocaval
obstruction. They concluded that the spiral saphenous vein
graft was a good conduit for superior vena cava bypass;
however, results were disappointing when used for IVC
obstruction. In their series, 43% of patients with spiral vein
IVC reconstructions required additional procedures, and
only 29% of veins were patent at a median follow-up of 2
years. Only 7 of 11 patients (64%) with abdominal or pelvic
polytetrafluoroethylene bypass grafts had patent grafts after
mean follow-up of 9 months.
Endovascular techniques have reinvigorated the treat-
ment of stenoses and occlusions involving large veins. The
goal of endovascular interventions is to provide a safe, less
invasive approach to management of central venous ob-
struction. In patients with underlying malignancy causing
large vein obstruction, endovascular techniques have been
used for palliation for a number of years. However, venous
occlusion due to benign disease poses a different challenge,
because prolonged patency must be maintained. Early pa-tency rates reported for PTA alone were good; however,
long-term results have been disappointing. Frequently re-
peat dilations are required, commonly because of recoil and
fibrosis of the venous segment.3,4
As stent technology and design have advanced, stenting
procedures have been associated with improved patency
rates and have decreased the need for repeat interven-
tion.6,7 In the venous system, most reports are on the use of
stents to treat malignant superior vena cava obstruc-
tion.8-11 Gaines et al8 reported their experience in 20
patients with Gianturco Z stents. Initial success was
achieved in 90% of patients, and the longer term secondary
patency rate was 75%. Although there are now reports of
good short-term and mid-term results in treatment of
chronic IVC occlusions with endovascular stent placement,
the procedure is still not well established.
In a report by Razavi et al,12 17 patients with IVC
occlusion underwent endovascular stent placement over 6
years. Five of these patients had acute thrombosis, and 4
had malignancy. Technical success was achieved in 15
patients (88%). Primary patency after mean follow-up of 19
months was 80%. There were no procedure-related compli-
cations. Hartung et al13 described 2 patients with IVC
occlusion caused by retroperitoneal fibrosis and treated
with angioplasty and stenting, reporting excellent clinical,
hemodynamic, and imaging results at 36 and 51 months.
Stenting of the intrahepatic vena cava in patients with
Budd-Chiari syndrome has been associated with excellent
technical and clinical success, and intermediate patency
rates of 70% to 100%.14 On the basis of our experience,
angioplasty in chronically occluded veins does not work,
because there often is extensive recoil. If uninterrupted
blood flow from the lower extremities to the right atrium
can be established, the occluded segments of the veins
often require stenting, which in our experience has worked
well. In fact, the incidence of intimal hyperplasia in IVC or
iliac vein stents is low. We now have several patients more
than 5 years after therapy with widely patent stents. How-
ever, most of these patients had acute on chronic deep
venous thrombosis, and therefore we have not included
them in this report. We believe these techniques should be
used in younger patients, if they have symptoms to warrant
treatment. Such symptoms would include lower extremity
pain and edema; skin changes of eczema, pigmentation,
and ulcerations; back pain; inguinal, abdominal, and tho-
racic varicosities; and impaired kidney or liver function.
Patients who have adequately compensated venous drain-
age through collateral vessels should not be treated with
extensive stenting, because the long-term patency of those
stents is unknown. We frequently use both Wallstents and
Z stents in the treatment of long-segment IVC occlusion.
They both have excellent radial force and work well in the
IVC. Traditionally, Z stents have been used more often in
the SVC and inominate veins. They have large interstices,
and can be deployed across the origin of vessels without
compromising flow through those vessels. In case 2 the
stents were carried to the right atrial junction, and therefore
had to cover the origin of the hepatic veins. The suprahe-
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long-standing occlusion in the infrahepatic IVC; hence
most of the blood flow from the abdomen, pelvis, and
lower extremity was being shunted through collateral ves-
sels. Z stents were used to preserve the function of the
hepatic veins. On the other hand, Z stents require large
sheaths (16F for 15-mmZ stents, 20F for 20-mmZ stents.)
Therefore, if covering the origin of vessels is not an issue, as
in case 1,Wallstents would be a good alternative.Wallstents
exist in a multitude of sizes and lengths, and are easily
deployable with relatively small sheaths.
Proper pharmacotherapy after extensive recanalization
has not been established. Recent literature suggests that
extended anticoagulation therapy after acute venous
thrombosis is recommended. Therefore it seems intuitive
that this same approach should be followed after interven-
tion. We also favor platelet inhibition when placing a pros-
thesis (stent) into the IVC, because platelet activation and
deposition is a potent stimulus for fibrin formation.
CONCLUSION
The initial data on the short-term and intermediate-
term results of endovascular stent treatment of the chroni-
cally occluded IVC is encouraging. This sometimes debili-
tating condition should no longer be thought of as
incurable, with surgical reconstruction being reserved for a
select few. Endovascular treatment is a potentially effective
alternative in patients in whom symptoms are poorly con-
trolled with supportive therapy. These 2 cases demonstrate
the dramatic and rapid improvement that can be achieved
with recanalization of long-standing IVC obstruction, re-
lieving severe lower extremity venous hypertension. We are
now recommending this percutaneous approach in our
patients with chronic postthrombotic vena cava occlusion.
While long-term results are not available, we do not believe
that patients will be worse off than they would be with
ongoing iliocaval obstruction. If recurrent stenosis were to
occur, repeat intervention can be offered, with anticipatedREFERENCES
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